Latest News ISPOR HTA Council Chair presents at the 1st China HTA Conference New EU law to inform medicine pricing Health technology assessments receive European Parliament backing European Parliament further clarifies Commission proposal on HTA for medical technologies New Law to Boost EU-level Cooperation on Health Tech Assessments Ghana receives accolades for progress in universal health coverage EUnetHTA Magazine – Summer 2018 Step therapy will drive drug-price concessions, AHIP says Professor says HSE should ‘take seriously’ cheaper medicines CVS sets a cost-effectiveness threshold for health plan coverage of most new drugs Irish HTA Official Calls for All New Patients to Start With Biosimilars IHE assesses evidence grading systems for HTA research This Drug Is Safe and Effective. Wait. Compared With What? Patient group input requested for a new Joint Assessment on a medicinal product for Diabetes Type 1 ECRI Will Host Retired AHRQ Clinical Decision-Making Guidelines New WHO report reviews medicines reimbursement policies in Europe The proposed European Commission Regulation on HTA: a golden opportunity for patients and health budgets Getting it right: EPHA recommendations on how to improve the European Commission proposal on Health Technology Assessment (HTA) Canada Allows Aligned Regulatory Drug Reviews Between Health Canada and HTA Orgs #EAPM – EU heavyweights show Commission #HTA proposal yellow card Upcoming Events ISPOR Warsaw 2019 March 27 - 28, 2019 Warsaw, Poland CADTH Symposium April 14 - 16, 2019 Edmonton, Alberta Canada Save the Date: HEOR Short Courses (at ISPOR 2019) May 18 - 19, 2019 New Orleans, LA United States ISPOR 2019 May 18 - 22, 2019 New Orleans, LA United States
The proposed European Commission Regulation on HTA: a golden opportunity for patients and health budgets
Getting it right: EPHA recommendations on how to improve the European Commission proposal on Health Technology Assessment (HTA)
